Reem Ghinnagow

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Combined JAK inhibition and PD-1 immunotherapy for non-small cell lung cancer patients.

Combined JAK inhibition and PD-1 immunotherapy for non-small cell lung cancer patients.

Journal: Science (New York, N.Y.)

Published: June 20, 2024

Targeting peptide antigens using a multiallelic MHC I-binding system.

Targeting peptide antigens using a multiallelic MHC I-binding system.

Journal: Nature biotechnology

Published: May 02, 2024

Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8+ T cells.

Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8+ T cells.

Journal: Cancer cell

Published: April 11, 2024

Abnormal functional lymphoid tolerance and enhanced myeloid exocytosis are characteristics of resting and stimulated PBMCs in cystic fibrosis patients.

Abnormal functional lymphoid tolerance and enhanced myeloid exocytosis are characteristics of resting and stimulated PBMCs in cystic fibrosis patients.

Journal: Frontiers in immunology

Published: December 23, 2023

p53 promotes revival stem cells in the regenerating intestine after severe radiation injury.

p53 promotes revival stem cells in the regenerating intestine after severe radiation injury.

Journal: bioRxiv : the preprint server for biology

Published: May 10, 2023

Isolation of Epithelial and Stromal Cells from Colon Tissues in Homeostasis and Under Inflammatory Conditions.

Isolation of Epithelial and Stromal Cells from Colon Tissues in Homeostasis and Under Inflammatory Conditions.

Journal: Bio-protocol

Published: March 30, 2023

p53 promotes revival stem cells in the regenerating intestine after severe radiation injury.

p53 promotes revival stem cells in the regenerating intestine after severe radiation injury.

Journal: Nature communications

Published: March 03, 2023

Pseudomonas Aeruginosa Lung Infection Subverts Lymphocytic Responses through IL-23 and IL-22 Post-Transcriptional Regulation.

Pseudomonas Aeruginosa Lung Infection Subverts Lymphocytic Responses through IL-23 and IL-22 Post-Transcriptional Regulation.

Journal: International journal of molecular sciences

Published: June 21, 2022

Targeted Co-delivery of Tumor Antigen and α-Galactosylceramide to CD141+ Dendritic Cells Induces a Potent Tumor Antigen-Specific Human CD8+ T Cell Response in Human Immune System Mice.

Targeted Co-delivery of Tumor Antigen and α-Galactosylceramide to CD141+ Dendritic Cells Induces a Potent Tumor Antigen-Specific Human CD8+ T Cell Response in Human Immune System Mice.

Journal: Frontiers in immunology

Published: April 18, 2020

Enhancement of Adjuvant Functions of Natural Killer T Cells Using Nanovector Delivery Systems: Application in Anticancer Immune Therapy.

Enhancement of Adjuvant Functions of Natural Killer T Cells Using Nanovector Delivery Systems: Application in Anticancer Immune Therapy.

Journal: Frontiers in immunology

Published: June 01, 2017

Co-delivery of the NKT agonist α-galactosylceramide and tumor antigens to cross-priming dendritic cells breaks tolerance to self-antigens and promotes antitumor responses.

Co-delivery of the NKT agonist α-galactosylceramide and tumor antigens to cross-priming dendritic cells breaks tolerance to self-antigens and promotes antitumor responses.

Journal: Oncoimmunology

Published: April 28, 2017

Targeted delivery of α-galactosylceramide to CD8α+ dendritic cells optimizes type I NKT cell-based antitumor responses.

Targeted delivery of α-galactosylceramide to CD8α+ dendritic cells optimizes type I NKT cell-based antitumor responses.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: June 11, 2014

Showing 1-12 of 12

Last Updated: 09/26/2026